To determine whether addition of neoadjuvant chemotherapy before definite CCRT increase progression-free survival(PFS) compared with CCRT only 18 months after the enrollment of the last patients [clinicaltrials_resource:5c49a4d4df7ab0fd22d0474dd516c34c]
no neoadjuvant chemotherapy before definitive CCRT
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
To determine whether addition of neoadjuvant chemotherapy before definite CCRT increase progression-free survival(PFS) compared with CCRT only 18 months after the enrollment of the last patients [clinicaltrials_resource:5c49a4d4df7ab0fd22d0474dd516c34c]
no neoadjuvant chemotherapy before definitive CCRT
Bio2RDF identifier
5c49a4d4df7ab0fd22d0474dd516c34c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5c49a4d4df7ab0fd22d0474dd516c34c
measure [clinicaltrials_vocabulary:measure]
To determine whether addition ...... l(PFS) compared with CCRT only
time frame [clinicaltrials_vocabulary:time-frame]
18 months after the enrollment of the last patients
description
no neoadjuvant chemotherapy before definitive CCRT
identifier
clinicaltrials_resource:5c49a4d4df7ab0fd22d0474dd516c34c
title
To determine whether addition ...... nrollment of the last patients
@en
type
label
To determine whether addition ...... 9a4d4df7ab0fd22d0474dd516c34c]
@en